INNATE PHARMA SA-SPONS ADR (IPHA)

US45781K2042 - ADR

2.3  +0.14 (+6.48%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to IPHA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.09. This target is 208.09% above the current price.
IPHA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about IPHA.
In the previous month the buy percentage consensus was at a similar level.
IPHA was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 2.302.656.807.0914.33 - 15.27% 195.68% 208.09% 523.12%
Up and Down Grades
Date Firm Action Rating
2024-06-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-16 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-24 HC Wainwright & Co. Reiterate Buy
2022-11-15 SVB Leerink Maintains Outperform
2022-09-16 Citigroup Maintains Buy
2022-08-02 SVB Leerink Maintains Outperform
2022-05-11 SVB Leerink Maintains Outperform
2021-09-17 SVB Leerink Maintains Outperform
2021-09-03 SVB Leerink Upgrade Market Perform -> Outperform
2021-09-02 SVB Leerink Upgrade Market Perform -> Outperform